Article Sidebar
Published:
Jan 15, 2025Keywords:
Article Details
The author(s) retain copyright on work published by AOSIS unless specified otherwise.
Licensing and publication rights
Author(s) of work published by AOSIS are required to grant AOSIS the unlimited rights to publish the definitive work in any format, language and medium, for any lawful purpose. AOSIS requires journal authors to publish their work in open access under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence.
The authors retain the non-exclusive right to do anything they wish with the published article(s), provided attribution is given to the applicable journal with details of the original publication, as set out in the official citation of the article published in the journal. The retained right specifically includes the right to post the article on the authors’ or their institution’s websites or in institutional repositories.
Previously published work may have been published under a different licence. We advise the community that if they would like to reuse the work to consult the applicable licence at article level.
Note: If you need to comply with your funding body policy, you can apply for the CC BY license after your manuscript is accepted for publication.
Main Article Content
The use of traditional and complementary medicine by cancer patients in SSA: A scoping review
Ammaarah Sheik Adam
Varsha Bangalee
Frasia Oosthuizen
Abstract
Background: The rate of traditional and complementary medicine (T&CM) use is increasing worldwide, including among cancer patients who are often willing to try alternate therapies. Despite T&CM popularity in sub-Saharan Africa (SSA), there are limited data on its use with conventional treatments.
Aim: This scoping review aims to describe the prevalence of use, reasons for use, most common types of T&CM used, patient satisfaction with T&CM and disclosure of T&CM use to physicians among cancer patients in SSA.
Methods: A systematic literature search was conducted for articles published from 2013 to 2022 across four databases: PubMed, ScienceDirect, Google Scholar and EBSCOhost. A scoping review approach was used to map relevant literature. Forty-six articles were assessed based on their titles and abstracts. After full-text screening, 10 articles were included.
Results: Average T&CM use was calculated to be 66.7%. Reasons for T&CM use included: to improve psychological well-being, boost the body’s immunity and provide symptomatic relief. An average of 21.2% of T&CM users informed their physician. Nine articles addressed patient satisfaction with T&CM. An average of 39.1% of patients reported general T&CM satisfaction.
Conclusion: The use of T&CM is common among cancer patients. It is important for healthcare providers to expand their knowledge in order to counsel patients and avoid potential hazards when combining T&CM with conventional treatments.
Contribution: These findings highlight commonly used T&CM and provide insight on the portion of cancer patients informing their doctors about T&CM use. This information will help understand the attitude cancer patients have towards T&CM.
